![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Moderna Signs Deal with Spanish Manufacturer for COVID-19 Vaccine Supply
Moderna Signs Deal with Spanish Manufacturer for COVID-19 Vaccine Supply
![Moderna logo](https://www.fdanews.com/ext/resources/test/Drug-Images4/Moderna-logo.jpg?t=1589311392&width=430)
July 10, 2020
Moderna has teamed up with Spain’s Laboratorios Farmacéuticos Rovi (ROVI) for large-scale manufacturing of its COVID-19 vaccine candidate mRNA-1273.
Under the agreement, ROVI will create a new production line at its facility in Madrid to produce hundreds of millions of doses for markets outside of the U.S.
Moderna signed a similar deal with Indiana-based Catalent last month to manufacture an initial 100 million doses for the U.S.
Upcoming Events
-
21Oct